Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is FINGOLIMOD HYDROCHLORIDE USP, with a corresponding US DMF Number 26807.
Remarkably, this DMF maintains an Active status since its submission on February 20, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 14, 2013, and payment made on February 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II